Table 3.
A. Unadjusted hazard ratios: | ||||
---|---|---|---|---|
Spirometric Group | Unadjusted Hazard Ratio (95% CI) for mortality | |||
Normal Pulmonary Function † | 1.00 | |||
FEV1/FVC < .70: FEV1 Stage | GOLD Stage 1 ≥ 80%Pred | GOLD Stage 2 50-79%Pred | GOLD Stage 3/4 < 50%Pred | Total |
≥ 5th SR-tile | 1.25 (1.04, 1.50) | 1.59 (1.29, 1.96) | NA | 1.35 (1.14, 1.61) |
< 5th SR-tile | NA | 2.27 (1.83, 2.81) | 3.94 (3.08, 5.03) | 2.85 (2.36, 3.45) |
Total | 1.25 (1.04, 1.50) | 1.81 (1.51, 2.16) | 3.93 (3.08,5.02) | 1.62 (1.37, 1.91) |
B. Adjusted hazard ratios: | ||||
Spirometric Group | Adjusted Hazard Ratio (95% CI) for mortality ‡ | |||
Normal Pulmonary Function † | 1.00 | |||
FEV1/FVC < .70: FEV1 Stage | GOLD Stage 1 ≥ 80%Pred | GOLD Stage 2 50-79%Pred | GOLD Stage 3/4 < 50%Pred | Total |
≥ 5th SR-tile | 1.03 (0.85, 1.26) n = 443 |
1.11 (0.91, 1.36) n = 209 |
NA n = 0 |
1.06 (0.89, 1.25) n = 652 |
< 5th SR-tile | NA n = 0 |
1.83 (1.41, 2.37) n = 105 |
2.24 (1.65, 3.04) n = 74 |
2.01 (1.60, 2.54) n = 179 |
Total | 1.04 (0.85, 1.27) n = 443 |
1.31 (1.08, 1.59) n = 314 |
2.24 (1.65, 3.03) n = 74 |
1.24 (1.04, 1.47) n = 831 |
COPD = chronic obstructive pulmonary disease; FEV1 = forced expiratory volume in 1 second; FVC = forced vital capacity; %Pred = percent predicted; SR-tile = standardized residual percentile; GOLD = Global Initiative for Obstructive Lung Disease; LLN = lower limit of normal; CI = confidence interval; NA = not applicable.
74 participants (3.6%) were excluded because of missing covariates and 87 (3.5%) were excluded because of restrictive pulmonary physiology, i.e., FEV1/FVC ≥ .70 and FVC < LLN.
Defined by an FEV1/FVC ≥ .70 and FVC ≥ LLN.
Covariates included age, age2, height, sex, ethnicity, smoking history, BMI, BMI2, BMI3, memory impairment, self-reported health status by time interaction, and chronic conditions. All covariates were significant at the p <.05 level, except age2 at a p value of .196 but this was kept in the model because we used the .20 level for higher order terms.